Literature DB >> 20480410

Expression of sphingosine-1-phosphate receptors and lysophosphatidic acid receptors on cultured and xenografted human colon, breast, melanoma, and lung tumor cells.

Reinhard Müller1, Christoph Berliner, Jessica Leptin, Daniel Pörtner, Wojciech Bialecki, Burkhard Kleuser, Udo Schumacher, Novica M Milićević.   

Abstract

The lysophospholipids sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) are small lipid molecules with a variety of physiological roles. Additionally, their involvement in the initiation and progression of malignant tumors has been increasingly recognized in recent years. However, the data on the expression of S1P and LPA receptors on different cancer cells are very few. Real-time polymerase chain reaction was used for the analysis of mRNA expression of five S1P((1-5)) and three LPA((1-3)) receptors on a large panel of 13 colon, breast, melanoma, and lung cancer cell lines. Furthermore, the modulation of S1P and LPA receptor mRNA expression was studied upon xenotransplantation of tumor cells into severe combined immunodeficient (SCID) mice. The S1P and LPA receptors were expressed to a variable degree on all tumor cell lines tested (with exception of colon cancer SW480). Most notably, tumor cell lines in vitro expressed S1P(2) mRNA that was down-regulated upon xenotransplantation, whereas LPA(2) receptor mRNA was strongly expressed both in vitro and in vivo (except by breast cancer cells). The latter was especially distinctive for small cell lung tumor cells. The S1P and LPA receptors are differentially expressed on tumor cell lines in vitro. Their expression is modulated upon xenografting into SCID mice in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20480410     DOI: 10.1007/s13277-010-0043-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  34 in total

Review 1.  Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.

Authors:  Jason G Cyster
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

2.  Sphingosine-1-phosphate inhibits motility of human breast cancer cells independently of cell surface receptors.

Authors:  F Wang; J R Van Brocklyn; L Edsall; V E Nava; S Spiegel
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

Review 3.  Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.

Authors:  Dagmar Meyer zu Heringdorf; Karl H Jakobs
Journal:  Biochim Biophys Acta       Date:  2006-10-04

Review 4.  Use of immunodeficient mice in metastasis research.

Authors:  B S Mitchell; U Schumacher
Journal:  Br J Biomed Sci       Date:  1997-12       Impact factor: 3.829

Review 5.  Lysophospholipid receptors: signaling and biology.

Authors:  Isao Ishii; Nobuyuki Fukushima; Xiaoqin Ye; Jerold Chun
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

6.  Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.

Authors:  Kayo Arikawa; Noriko Takuwa; Hironori Yamaguchi; Naotoshi Sugimoto; Joji Kitayama; Hirokazu Nagawa; Kazuhiko Takehara; Yoh Takuwa
Journal:  J Biol Chem       Date:  2003-06-16       Impact factor: 5.157

7.  Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells.

Authors:  Yuhuan Xie; Terra C Gibbs; Yurii V Mukhin; Kathryn E Meier
Journal:  J Biol Chem       Date:  2002-06-25       Impact factor: 5.157

8.  A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells.

Authors:  Saubhik Sengupta; Yi-Jin Xiao; Yan Xu
Journal:  FASEB J       Date:  2003-06-03       Impact factor: 5.191

9.  Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells.

Authors:  Hironori Yamaguchi; Joji Kitayama; Noriko Takuwa; Kayo Arikawa; Isao Inoki; Kazuhiko Takehara; Hirokazu Nagawa; Yoh Takuwa
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

10.  Human neural progenitors express functional lysophospholipid receptors that regulate cell growth and morphology.

Authors:  Jillian H Hurst; Jennifer Mumaw; David W Machacek; Carla Sturkie; Phillip Callihan; Steve L Stice; Shelley B Hooks
Journal:  BMC Neurosci       Date:  2008-12-11       Impact factor: 3.288

View more
  8 in total

1.  Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis.

Authors:  Sue-Chin Lee; Yuko Fujiwara; Jianxiong Liu; Junming Yue; Yoshibumi Shimizu; Derek D Norman; Yaohong Wang; Ryoko Tsukahara; Erzsebet Szabo; Renukadevi Patil; Souvik Banerjee; Duane D Miller; Louisa Balazs; Manik C Ghosh; Christopher M Waters; Tamas Oravecz; Gabor J Tigyi
Journal:  Mol Cancer Res       Date:  2014-08-26       Impact factor: 5.852

Review 2.  Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.

Authors:  Mari Gotoh; Yuko Fujiwara; Junming Yue; Jianxiong Liu; SueChin Lee; James Fells; Ayako Uchiyama; Kimiko Murakami-Murofushi; Stephen Kennel; Jonathan Wall; Renukadevi Patil; Renuka Gupte; Louisa Balazs; Duane D Miller; Gabor J Tigyi
Journal:  Biochem Soc Trans       Date:  2012-02       Impact factor: 5.407

3.  Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells.

Authors:  Andrew Hsu; Wenliang Zhang; Jen-Fu Lee; Jin An; Prasanna Ekambaram; Jingjing Liu; Kenneth V Honn; Carolyn M Klinge; Menq-Jer Lee
Journal:  Int J Oncol       Date:  2012-02-16       Impact factor: 5.650

Review 4.  Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy.

Authors:  David N Brindley; Fang-Tsyr Lin; Gabor J Tigyi
Journal:  Biochim Biophys Acta       Date:  2012-08-29

5.  Sphingolipid metabolism in colorectal adenomas varies depending on histological architecture of polyps and grade of nuclear dysplasia.

Authors:  Krzysztof Kurek; Bartłomiej Łukaszuk; Agnieszka Świdnicka-Siergiejko; Paweł Rogalski; Eugeniusz Wróblewski; Adrian Chabowski; Andrzej Dąbrowski; Małgorzata Żendzian-Piotrowska
Journal:  Lipids       Date:  2015-01-17       Impact factor: 1.880

6.  LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways.

Authors:  Fernanda Leve; Rubem J Peres-Moreira; Renata Binato; Eliana Abdelhay; José A Morgado-Díaz
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

Review 7.  Metabolism, physiological role, and clinical implications of sphingolipids in gastrointestinal tract.

Authors:  Krzysztof Kurek; Bartłomiej Łukaszuk; Dominika M Piotrowska; Patrycja Wiesiołek; Anna Małgorzata Chabowska; Małgorzata Zendzian-Piotrowska
Journal:  Biomed Res Int       Date:  2013-09-05       Impact factor: 3.411

8.  Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells.

Authors:  Loubna Abdel Hadi; Clara Di Vito; Giovanni Marfia; Anita Ferraretto; Cristina Tringali; Paola Viani; Laura Riboni
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.